Preventable central line infections linked to 40% mortality in ICUs, Lancet study reports

A Lancet study across Indian ICUs finds preventable central line bloodstream infections causing high mortality, driven by ...
Nasdaq

Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the publication of ...
The Union

Dignity Health Sierra Nevada Memorial Hospital marks five years of zero Central Line Infections

(SNMH) announced a significant milestone in patient safety: five consecutive years without a single Central Line-Associated Bloodstream Infection (CLABSI). This outstanding achievement demonstrates SN ...
Morningstar

Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)

In the PCCU, where VALGuard® compliance was highest, CLABSI rates decreased by 100% – from an average monthly rate of 1.8 CLABSIs per 1,000 line days in the 15 months pre-implementation to 0.0 in the ...